April 22, 2024

Wittenstein Biointelligence Award

Wittenstein Biointelligence Award

Apply now!

The Wittenstein Biointelligence Award will be awarded on October 6, 2026, as part of a festive ceremony at the “Biointelligence Congress” in Stuttgart. The first-placed startup / company will receive €20,000, whereas the first-placed individual from a research institution will receive €10,000.

About the Wittenstein Biointelligence Award

The biological transformation of industry is crucial for making production sustainable without sacrificing prosperity. The aim is to sustainably optimize established product and production structures by promoting innovative approaches at the interface of life sciences, engineering, and information technology.

The Wittenstein Biointelligence Award recognizes novel approaches or solutions in the fields of biotechnology, information technology and production technology. Submitted proposals should demonstrate an effective integration of information technology, production engineering, biotechnology and present integrative approaches that are as holistic as possible.

Particular emphasis is placed on ideas having a clear impact on sustainability, for example by reducing the carbon footprint, promoting renewable energies, reducing waste, or improving the ecological footprint.

Application

Are you working on a relevant innovation? Then seize this opportunity and apply now! The submission deadline is July 31, 2026.

Please send this completed application form to event@ipa.fraunhofer.de.

Check the application data sheet for the conditions of participation. Please take note that all award money winners are responsible for paying tax on their own award money.

Eligibility Criteria

Start-up / Company

  • Recently founded and established companies in the fields of biotechnology, AI, or related topics.
  • Interdisciplinary nature of the company/start-up: Companies that can demonstrate expertise in at least two of the following areas: biotechnology, artificial intelligence, production technology, and sustainability (particularly integrative approaches).

Individuals from research institutions based in the EU

  • Researchers and academics: Individuals working at universities or research institutions with a focus on biotechnology, artificial intelligence, or sustainability.
  • Interdisciplinarity through a combination of expertise from at least two relevant fields must be demonstrated.
  • Doctoral students who can demonstrate relevant research work in overlapping areas of biotechnology, artificial intelligence, or sustainability.

Award criteria

  1. Innovation and originality: The idea should offer a novel approach or solution at the intersection of biotechnology,information technology and production technology. It should demonstrate creativity and provide an alternative to conventional methods.
  2. Feasibility and scalability: The concept should be practically implementable and have the potential for large-scale deployment. ​
  3. Industrial impact : Commercial exploitation and tech transfer potential, as well as the general impact should be highlighted.
  4. Ethical considerations: The idea should adhere to ethical standards, including the responsible use of technology and consideration of long-term societal impacts. ​
  5. Impact on sustainability: The idea should have a clear impact on sustainability. This may include reducing the carbon footprint, promoting the use of renewable energy, reducing waste, or improving ecological balance.

Mit dem Preis werden innovative Lösungen an der Schnittstelle von Biologie, Technologie und Digitalisierung ausgezeichnet. Der Preis wird im Rahmen des Biointelligence Congress 2026 am 06. Oktober 2026 auf der Messe Stuttgart verliehen.

🏆 Preisgeld:
• 20.000 € für Unternehmen / Start-ups
• 10.000 € für Einzelpersonen

Gesucht werden innovative Projekte und Start-ups aus Bereichen wie:

  • Biointelligenz
  • Biotechnologie
  • KI & Digitalisierung
  • Robotik
  • Nachhaltige Produktion
  • Life Sciences

Die Teilnahme bietet neben dem Preisgeld auch Sichtbarkeit im Biointelligenz-Ökosystem sowie Zugang zu Industrie, Forschung und Investoren.

📅 Bewerbungsfrist: 31. Juli 2026

Weitere Informationen: Hier

register now

Our latest News

discover more
BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies

BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies

Ridgefield, CT, USA, July 9, 2026 – BioMed X, a leading innovation engine for pharma, and Boehringer Ingelheim today announced the launch of a new research team at XSeed Labs, the established innovation incubator embedded within Boehringer’s U.S. R&D headquarters in Ridgefield, Connecticut. The newly established research team, Team NIB (New Platform for Next-Generation Intraocular […]

Clinical Trial on Mild Stroke: Inpatient or Outpatient Treatment?

Clinical Trial on Mild Stroke: Inpatient or Outpatient Treatment?

Researchers at Heidelberg University’s Faculty of Medicine are investigating a new care model for older adults with mild strokes at the Heidelberg University Hospital’s Department of Neurology. The Joint Federal Committee (G-BA) is funding the ARTIFICE study with approximately 2.4 million euros. Full Text in German below. Klinische Studie zu leichtem Schlaganfall: stationär oder ambulant […]

VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline

VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline

Ardigen platform supports VERAXA’s in-house AI capabilities to optimize cancer target pair selection for conditionally active t cell engagers (TCEs) and antibody drug conjugates (ADCs) ZURICH, SWITZERLAND – July 13, 2026 — VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced a collaboration with Ardigen S.A., an AI-driven computational partner for modern […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp